Barriers to tumor mutation burden (TMB) testing in NSCLC patients in the US and EU.

Angel, WH; Edathanal, C; Krishnam, M; De Richter, P; Levent, A

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):